Home > Pressemitteilung: Promising Active Ingredient for Lupus ...
The Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for obinutuzumab (Gazyva®) for the treatment of lupus nephritis.
A 41-year-old gym lover, Jamie Samnang, who thought her rash was a mosquito bite, had a highly contagious ringworm infection, which she picked up from her gym equipment. Jamie said a small rash slowly ...
New research reveals disturbing nightmares and hallucinations may serve as early warning signs of lupus, potentially helping patients receive treatment sooner.
HealthDay News — For patients with systemic lupus erythematosus (SLE) and pericarditis, recurrence of pericarditis occurs in more than 20 percent of patients and associated factors include younger age ...
Living with lupus can be overwhelming, says columnist Candace Semien, but it's important to hold tight and fight for yourself ...
From eczema to allergic reactions to bug bites, here’s what common skin rashes look like in photos, and the symptoms that can help you I.D. the condition.
Chimeric antigen receptor T-cell therapy improves not only lupus disease activity but also other related conditions that ...
Patients whose autoimmune disorders such as lupus were initially dismissed by doctors as psychosomatic show long-lasting ...
The U.S. Food and Drug Administration (FDA) has accepted Genentech’s Supplemental Biologics License Application (sBLA) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback